MY186939A - Adherens junction function enhancing agent - Google Patents
Adherens junction function enhancing agentInfo
- Publication number
- MY186939A MY186939A MYPI2017702182A MYPI2017702182A MY186939A MY 186939 A MY186939 A MY 186939A MY PI2017702182 A MYPI2017702182 A MY PI2017702182A MY PI2017702182 A MYPI2017702182 A MY PI2017702182A MY 186939 A MY186939 A MY 186939A
- Authority
- MY
- Malaysia
- Prior art keywords
- enhancing agent
- function enhancing
- adherens junction
- junction function
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Provided are an adherens junction function enhancing agent, an E-cadherin enhancing agent, an intercellular adhesion strength enhancing agent, an epithelial barrier function enhancing agent, and a resistance enhancing agent containing at least one selected from the group consisting of ascorbyl phosphate and a salt thereof, vitamin E and a derivative thereof, copper chlorophyll and a salt thereof, and lysozyme chloride.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014259645 | 2014-12-24 | ||
PCT/JP2015/085867 WO2016104524A1 (en) | 2014-12-24 | 2015-12-22 | Agent for enhancing adherens junction function |
Publications (1)
Publication Number | Publication Date |
---|---|
MY186939A true MY186939A (en) | 2021-08-26 |
Family
ID=56150540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2017702182A MY186939A (en) | 2014-12-24 | 2015-12-22 | Adherens junction function enhancing agent |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP6755185B2 (en) |
KR (1) | KR20170097013A (en) |
CN (2) | CN107106539A (en) |
MY (1) | MY186939A (en) |
WO (1) | WO2016104524A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7412869B2 (en) * | 2016-08-05 | 2024-01-15 | 小林製薬株式会社 | Gum care agent and oral composition for gum care containing the same |
JP7237465B2 (en) * | 2018-05-25 | 2023-03-13 | ポーラ化成工業株式会社 | A screening method using the expression levels of the occludin gene, the claudin gene, and the zo-1 gene under hypoxic conditions as an indicator, an inhibitor of claudin gene expression reduction, an inhibitor of cell adhesion apparatus function deterioration, and a reduction in skin barrier function ameliorating or preventive agent |
TW202012925A (en) * | 2018-05-25 | 2020-04-01 | 日商寶麗化成工業股份有限公司 | Method for screening for components that improve condition of aged or hypoxic skin, and method for estimating oxygen level of subdermal tissue or fibrosis level of subdermal adipocytes as index of subdermal tissue viscoelasticity |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6093706A (en) * | 1992-03-04 | 2000-07-25 | Bioresponse, L.L.C. | Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders |
JPH10236935A (en) * | 1996-08-02 | 1998-09-08 | Kao Corp | Oral solid preparation |
JP2001055318A (en) * | 1999-08-17 | 2001-02-27 | Lion Corp | Composition for oral cavity |
CA2659398A1 (en) * | 2006-08-02 | 2008-02-07 | Wm. Wrigley Jr. Company | Oral compositions effective for the treatment of oral cavity malodor associated with the consumption of odor-causing compounds |
JP4300370B2 (en) * | 2007-03-13 | 2009-07-22 | 春三 小林 | Epithelial improving agent |
WO2014103475A1 (en) * | 2012-12-27 | 2014-07-03 | 株式会社林原 | Skin-exterior anti-ageing composition and production method therefor |
CN103641837B (en) * | 2013-11-15 | 2016-03-23 | 云南瑞宝生物科技股份有限公司 | A kind of method of chlorophyll copper sodium extracting from silkworm excrement |
CN103751031A (en) * | 2014-01-09 | 2014-04-30 | 广州市科玮生物技术有限公司 | Mouthwash containing antimicrobial peptide and sodium copper chlorophyllin and preparation method of mouthwash |
-
2015
- 2015-12-22 MY MYPI2017702182A patent/MY186939A/en unknown
- 2015-12-22 CN CN201580071316.2A patent/CN107106539A/en active Pending
- 2015-12-22 KR KR1020177013772A patent/KR20170097013A/en not_active Application Discontinuation
- 2015-12-22 WO PCT/JP2015/085867 patent/WO2016104524A1/en active Application Filing
- 2015-12-22 CN CN202010607375.XA patent/CN111658640A/en active Pending
- 2015-12-22 JP JP2016566402A patent/JP6755185B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JPWO2016104524A1 (en) | 2017-10-05 |
JP6755185B2 (en) | 2020-09-16 |
WO2016104524A1 (en) | 2016-06-30 |
CN107106539A (en) | 2017-08-29 |
CN111658640A (en) | 2020-09-15 |
KR20170097013A (en) | 2017-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3108097A4 (en) | Zinc one piece link system | |
EP3183708A4 (en) | Location tracking system | |
EP3389542A4 (en) | Glove donning system | |
EP3316537A4 (en) | Dpd system | |
GB201716939D0 (en) | Nmes garment | |
EP3265397A4 (en) | Tabbed seal concepts | |
EP3206251A4 (en) | Lithium-air battery | |
EP3648047A4 (en) | Glove/logging system | |
EP3525611A4 (en) | Apparel for athletic activities | |
GB2574988B (en) | Neuromuscular junction: NMJ-on-chip | |
PL3697206T3 (en) | System for sorting insects | |
EP3678736A4 (en) | Self-shielded, integrated-control radiosurgery system | |
AU2016361427A8 (en) | Platinum anticancer agents | |
EP3335243A4 (en) | Tunnel barrier schottky | |
GB201711744D0 (en) | Barrier system | |
EP3338577A4 (en) | Vertical waistband | |
EP3270839B8 (en) | Barrier garment | |
EP3270903A4 (en) | Improved disulfide-containing alkyne linking agents | |
MY186939A (en) | Adherens junction function enhancing agent | |
EP3531854A4 (en) | Glove attachment system | |
EP3305255A4 (en) | Vest-type maternity belt | |
PL3568538T3 (en) | Smoke barrier system | |
EP3371376A4 (en) | Current shield | |
EP3377369A4 (en) | Strap locating arrangement | |
EP3363188A4 (en) | Presence systems, presence servers and presence agents |